Arcturus Therapeutics Holdings, Inc. (ARCT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Keros Therapeutics, Inc.

Innoviva, Inc.

Collegium Pharmaceutical, Inc.

Ardelyx, Inc.

NewAmsterdam Pharma Co. NV

REGENXBIO, Inc.

Arcturus Therapeutics Holdings, Inc.

Pharvaris NV

ACELYRIN, Inc.

POINT Biopharma Global, Inc.

Intercept Pharmaceuticals, Inc.

Why is Arcturus Therapeutics Holdings, Inc. ?

Poor Management Efficiency with a low ROE of 6.34%

The company has been able to generate a Return on Equity (avg) of 6.34% signifying low profitability per unit of shareholders funds

The company has declared negative results for the last 2 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at USD -61.21 MM
PRE-TAX PROFIT(Q) At USD -9.56 MM has Fallen at -63.85%
NET PROFIT(Q) At USD -9.56 MM has Fallen at -65.38%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -49.89%, its profits have fallen by -801.5%

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 13.68% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -49.89% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Arcturus Therapeutics Holdings, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Arcturus Therapeutics Holdings, Inc.

-46.8%

-0.83

95.80%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

52.66%

EBIT Growth (5y)

0.08%

EBIT to Interest (avg)

-48.70

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.01

Sales to Capital Employed (avg)

0.59

Tax Ratio

0.54%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

392.01%

ROE (avg)

6.34%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.84

EV to EBIT

0.69

EV to EBITDA

0.73

EV to Capital Employed

6.41

EV to Sales

-0.50

PEG Ratio

Dividend Yield

ROCE (Latest)

926.88%

ROE (Latest)

-16.84%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-30What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -61.21 MM

PRE-TAX PROFIT(Q)

At USD -9.56 MM has Fallen at -63.85%

NET PROFIT(Q)

At USD -9.56 MM has Fallen at -65.38%

NET SALES(Q)

Lowest at USD 14.15 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -104.71 %

Here's what is not working for Arcturus Therapeutics Holdings, Inc.

Net Sales

At USD 14.15 MM has Fallen at -48.44%

over average net sales of the previous four periods of USD 27.45 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -9.56 MM has Fallen at -63.85%

over average net sales of the previous four periods of USD -5.83 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -9.56 MM has Fallen at -65.38%

over average net sales of the previous four periods of USD -5.78 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -61.21 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales

Lowest at USD 14.15 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit Margin

Lowest at -104.71 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales